BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

Sarah A Holstein, Hervé Avet-Loiseau, Theresa Hahn, Christine M. Ho, Jens G. Lohr, Nikhil C. Munshi, Bruno Paiva, Marcelo C. Pasquini, Joseph D. Tario, Saad Z. Usmani, Paul K. Wallace, Katja Weisel, Philip L. McCarthy

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design.

Original languageEnglish (US)
Pages (from-to)641-648
Number of pages8
JournalBiology of Blood and Marrow Transplantation
Volume24
Issue number4
DOIs
StatePublished - Apr 2018

Fingerprint

Residual Neoplasm
Clinical Trials
Education
Bone Marrow
Technology
Transplants
trans-crotonin

Keywords

  • Immune profiling
  • Minimal residual disease
  • Multiple myeloma, autologous stem cell transplant

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling : Summary and Recommendations from the Organizing Committee. / Holstein, Sarah A; Avet-Loiseau, Hervé; Hahn, Theresa; Ho, Christine M.; Lohr, Jens G.; Munshi, Nikhil C.; Paiva, Bruno; Pasquini, Marcelo C.; Tario, Joseph D.; Usmani, Saad Z.; Wallace, Paul K.; Weisel, Katja; McCarthy, Philip L.

In: Biology of Blood and Marrow Transplantation, Vol. 24, No. 4, 04.2018, p. 641-648.

Research output: Contribution to journalReview article

Holstein, SA, Avet-Loiseau, H, Hahn, T, Ho, CM, Lohr, JG, Munshi, NC, Paiva, B, Pasquini, MC, Tario, JD, Usmani, SZ, Wallace, PK, Weisel, K & McCarthy, PL 2018, 'BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee', Biology of Blood and Marrow Transplantation, vol. 24, no. 4, pp. 641-648. https://doi.org/10.1016/j.bbmt.2017.12.774
Holstein, Sarah A ; Avet-Loiseau, Hervé ; Hahn, Theresa ; Ho, Christine M. ; Lohr, Jens G. ; Munshi, Nikhil C. ; Paiva, Bruno ; Pasquini, Marcelo C. ; Tario, Joseph D. ; Usmani, Saad Z. ; Wallace, Paul K. ; Weisel, Katja ; McCarthy, Philip L. / BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling : Summary and Recommendations from the Organizing Committee. In: Biology of Blood and Marrow Transplantation. 2018 ; Vol. 24, No. 4. pp. 641-648.
@article{d341bea36c71462881c565fd26e4befd,
title = "BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee",
abstract = "The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design.",
keywords = "Immune profiling, Minimal residual disease, Multiple myeloma, autologous stem cell transplant",
author = "Holstein, {Sarah A} and Herv{\'e} Avet-Loiseau and Theresa Hahn and Ho, {Christine M.} and Lohr, {Jens G.} and Munshi, {Nikhil C.} and Bruno Paiva and Pasquini, {Marcelo C.} and Tario, {Joseph D.} and Usmani, {Saad Z.} and Wallace, {Paul K.} and Katja Weisel and McCarthy, {Philip L.}",
year = "2018",
month = "4",
doi = "10.1016/j.bbmt.2017.12.774",
language = "English (US)",
volume = "24",
pages = "641--648",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

T2 - Summary and Recommendations from the Organizing Committee

AU - Holstein, Sarah A

AU - Avet-Loiseau, Hervé

AU - Hahn, Theresa

AU - Ho, Christine M.

AU - Lohr, Jens G.

AU - Munshi, Nikhil C.

AU - Paiva, Bruno

AU - Pasquini, Marcelo C.

AU - Tario, Joseph D.

AU - Usmani, Saad Z.

AU - Wallace, Paul K.

AU - Weisel, Katja

AU - McCarthy, Philip L.

PY - 2018/4

Y1 - 2018/4

N2 - The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design.

AB - The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design.

KW - Immune profiling

KW - Minimal residual disease

KW - Multiple myeloma, autologous stem cell transplant

UR - http://www.scopus.com/inward/record.url?scp=85040518117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040518117&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2017.12.774

DO - 10.1016/j.bbmt.2017.12.774

M3 - Review article

C2 - 29242112

AN - SCOPUS:85040518117

VL - 24

SP - 641

EP - 648

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 4

ER -